PMID- 23661628 OWN - NLM STAT- MEDLINE DCOM- 20140813 LR - 20211203 IS - 1523-4681 (Electronic) IS - 0884-0431 (Linking) VI - 28 IP - 11 DP - 2013 Nov TI - Metabolic regulation of osteoclast differentiation and function. PG - 2392-9 LID - 10.1002/jbmr.1976 [doi] AB - The osteoclast is a giant cell that resorbs calcified matrix by secreting acids and collagenolytic enzymes. The molecular mechanisms underlying metabolic adaptation to the increased biomass and energetic demands of osteoclastic bone resorption remain elusive. Here we show that during osteoclastogenesis the expression of both glucose transporter 1 (Glut1) and glycolytic genes is increased, whereas the knockdown of hypoxia-inducible factor 1-alpha (Hif1alpha), as well as glucose deprivation, inhibits the bone-resorbing function of osteoclasts, along with a suppression of Glut1 and glycolytic gene expression. Furthermore, the expression of the glutamine transporter solute carrier family 1 (neutral amino acid transporter), member 5 (Slc1a5) and glutaminase 1 was increased early in differentiation, and a depletion of L-glutamine or pharmacological inhibition of the Slc1a5 transporter suppressed osteoclast differentiation and function. Inhibition of c-Myc function abrogated osteoclast differentiation and function, along with a suppression of Slc1a5 and glutaminase 1 gene expression. Genetic and pharmacological inhibition of mammalian target of rapamycin (mTOR), as well as the activation of adenosine monophosphate (AMP)-activated protein kinase (AMPK), inhibited osteoclastogenesis. Thus, the uptake of glucose and glutamine and utilization of the carbon sources derived from them, coordinated by HIF1alpha and c-Myc, are essential for osteoclast development and bone-resorbing activity through a balanced regulation of the nutrient and energy sensors, mTOR and AMPK. CI - (c) 2013 American Society for Bone and Mineral Research. FAU - Indo, Yoriko AU - Indo Y AD - Department of Bone and Joint Disease, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan. FAU - Takeshita, Sunao AU - Takeshita S FAU - Ishii, Kiyo-Aki AU - Ishii KA FAU - Hoshii, Takayuki AU - Hoshii T FAU - Aburatani, Hiroyuki AU - Aburatani H FAU - Hirao, Atsushi AU - Hirao A FAU - Ikeda, Kyoji AU - Ikeda K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Bone Miner Res JT - Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research JID - 8610640 RN - 0 (Amino Acid Transport System ASC) RN - 0 (Glucose Transporter Type 1) RN - 0 (Hif1a protein, mouse) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Minor Histocompatibility Antigens) RN - 0 (Proto-Oncogene Proteins c-myc) RN - 0 (Slc1a5 protein, mouse) RN - 0 (Slc2a1 protein, mouse) RN - 0RH81L854J (Glutamine) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Amino Acid Transport System ASC/metabolism MH - Animals MH - Bone Resorption/enzymology/genetics/pathology MH - *Cell Differentiation/drug effects/genetics MH - Gene Expression Regulation/drug effects MH - Glucose/metabolism MH - Glucose Transporter Type 1/genetics/metabolism MH - Glutamine/pharmacology MH - Glycolysis/drug effects MH - Hypoxia-Inducible Factor 1, alpha Subunit/metabolism MH - Mice MH - Mice, Inbred C57BL MH - Minor Histocompatibility Antigens MH - Osteoclasts/drug effects/*metabolism/*pathology MH - Osteogenesis/drug effects/genetics MH - Proto-Oncogene Proteins c-myc/metabolism MH - TOR Serine-Threonine Kinases/metabolism OTO - NOTNLM OT - BIOENERGETICS OT - BIOSYNTHESIS OT - GLUTAMINOLYSIS OT - GLYCOLYSIS OT - OSTEOCLAST EDAT- 2013/05/11 06:00 MHDA- 2014/08/15 06:00 CRDT- 2013/05/11 06:00 PHST- 2013/03/10 00:00 [received] PHST- 2013/04/16 00:00 [revised] PHST- 2013/04/24 00:00 [accepted] PHST- 2013/05/11 06:00 [entrez] PHST- 2013/05/11 06:00 [pubmed] PHST- 2014/08/15 06:00 [medline] AID - 10.1002/jbmr.1976 [doi] PST - ppublish SO - J Bone Miner Res. 2013 Nov;28(11):2392-9. doi: 10.1002/jbmr.1976.